title: Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.
authors: Geriatric Psychiatry Research Program McLean Hospital Belmont, MA and Harvard Medical School Department of Psychiatry Boston, MA bforester@partners.org Geriatric Psychiatry Research Program McLean Hospital Belmont, MA and Harvard Medical School Department of Psychiatry Boston, MA Geriatric Psychiatry Research Program McLean Hospital Belmont, MA Harvard Medical School Department of Psychiatry Boston, MA and McLean Hospital Laboratory for Psychiatric Biostatistics Belmont, MA Geriatric Psychiatry Research Program McLean Hospital Belmont, MA Harvard Medical School Department of Psychiatry Boston, MA and Shervert Frazier Research Institute McLean Hospital Belmont, MA.
authors: Brent P
authors: BP
authors: Forester
authors: David G
authors: DG
authors: Harper
authors: Joanna
authors: J
authors: Georgakas
authors: Caitlin
authors: C
authors: Ravichandran
authors: Nethra
authors: N
authors: Madurai
authors: Bruce M
authors: BM
authors: Cohen
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D014451:Ubiquinone; C024989:coenzyme Q10